Home › Research › Tau biomarkers
Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases
Coysh T, Laban R, Veleva E, Heslegrave AJ, Darwent L, Holm-Mercer L, Mok TH, Hart MS et al.. Neurology, 2026-07-13
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background and objectives Prion diseases can mimic Alzheimer disease (AD) at presentation. Alzheimer's Association AD diagnostic criteria suggest that a single abnormal highly specific plasma biomarker (including p-tau217) is sufficient for a biological diagnosis. We investigated the performance of AD plasma biomarkers in distinguishing AD and prion diseases.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 345 participants. This cohort study examined how Alzheimer's disease plasma biomarkers, including p-tau217, performed in distinguishing Alzheimer's disease from prion diseases, which can mimic Alzheimer's disease at presentation. Reported effect size: 48.2%; AUC 0.554; AUC 0.514.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Coysh, T., Laban, R., Veleva, E., Heslegrave, A. J., Darwent, L., Holm-Mercer, L., et al. (2026). Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases. Neurology. https://doi.org/10.1212/wnl.0000000000214712
Vancouver
Coysh T, Laban R, Veleva E, Heslegrave AJ, Darwent L, Holm-Mercer L, et al. Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases. Neurology. 2026. doi:10.1212/wnl.0000000000214712. PMID: 42441927.
BibTeX
@article{coysh2026-42441927,
author = {Coysh, T. and Laban, R. and Veleva, E. and Heslegrave, A. J. and Darwent, L. and Holm-Mercer, L. and Mok, T. H. and Hart, M. S. and others},
title = {{Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases}},
journal = {Neurology},
year = {2026},
doi = {10.1212/wnl.0000000000214712},
pmid = {42441927},
url = {https://doi.org/10.1212/wnl.0000000000214712}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Alzheimer's Association AD diagnostic criteria suggest that a single abnormal highly specific plasma biomarker (including p-tau217) is sufficient for a biological diagnosis.
- We investigated the performance of AD plasma biomarkers in distinguishing AD and prion diseases.
- Methods We examined plasma biomarker data from patients with prion disease from a prospective cohort study recruited through the UK National Prion Clinic.
- Prion diseases were diagnosed clinically or with autopsy confirmation, and AD was diagnosed clinically with CSF biomarker confirmation.
Why it matters
This cohort study examined how Alzheimer's disease plasma biomarkers, including p-tau217, performed in distinguishing Alzheimer's disease from prion diseases, which can mimic Alzheimer's disease at presentation. It concerns diagnostic accuracy and does not test any treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designcohort study
- Participants345
- Effect size48.2%; AUC 0.554; AUC 0.514
- Evidence strengthModerate
How this study scored 64/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 345 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 3.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Simon Mead: h-index 89 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University College London: institution h-index 2,029 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 12 institution(s) in 4 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42441927) |
| Free to read | 2 / 2 | Free to read |
| Total | 64 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.